Brief: AB Science SA Says Consolidated Operating Loss Of EUR 13.4 Million As Of 31 December 2023, Compared With A Loss Of EUR 15.9 Million As Of 31 December 2022
15/05/2024 19:22
May 15 (Reuters) - AB Science SA ABS.PA :
* AB SCIENCE SA - CONSOLIDATED OPERATING LOSS OF EUR 13.4
MILLION
AS OF 31 DECEMBER 2023, COMPARED WITH A LOSS OF EUR 15.9 MILLION
AS OF 31 DECEMBER 2022
Source text for Eikon: ID:nGNE11PfcB
Further company coverage: ABS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AB Science SA
See all newsBrief: AB Science Expects To Resume AB8939 Phase 1 In Q1 2027 And Masitinib Phase 3 In Q4 2027
Brief: AB Science Discontinues Phase 2 AB20006, Phase 3 AB15003, Phase 3 AB20009 Studies
Brief: AB Science Temporarily Halts Europe Clinical Trials Ahead Of Strategic Reorganization
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041